Khaydar Yunusov | Drug Discovery and Development | Best Researcher Award

Khaydar Yunusov | Drug Discovery and Development | Best Researcher Award

Prof. Khaydar Yunusov at Institute of Polymer Chemistry and Physics Uzbekistan Academy of Sciences, Uzbekistan.

Prof. Khaydar Yunusov is a distinguished polymer chemist from Uzbekistan with extensive expertise in nanotechnology, cellulose chemistry, and biomaterials. Since 2007, he has held key research and leadership roles at the Institute of Polymer Chemistry and Physics, contributing significantly to polymer-based biomedical innovations. šŸ’Š He holds a Doctor of Science and leads groundbreaking projects on nanostructured antibacterial films, antiviral eye medications, and burn treatments. šŸ“˜ With several patents, international collaborations šŸŒ, and editorial roles in leading journals, Prof. Yunusov is a pioneering force in sustainable polymer research and nanomedical applications.

Publication ProfileĀ 

Orcid

Education

Prof. Khaydar Yunusov began his academic journey at the Tashkent Chemical Technological Institute, earning a Bachelor’s degree in Chemistry (2006) and a Master’s in Cellulose, Paper Chemistry, and Technology (2008). šŸ“˜ Driven by scientific excellence, he pursued a Doctor of Science in Technical Sciences (2009–2016), focusing on advanced polymer research. Since 2018, he has served as a Senior Scientific Researcher in Nanochemistry, Nanophysics, and Nanotechnology. 🧪 His research delves into nanostructured bactericidal preparations based on cellulose and its derivatives, emphasizing synthesis, properties, and production technologies. 🧬 His academic background provides a solid foundation for pioneering innovations in polymer science.

Experience

Prof. Khaydar Yunusov has cultivated a rich professional career in polymer science, beginning in 2007 as a researcher at the Institute of Polymer Chemistry and Physics, Uzbek Academy of Sciences, Tashkent. šŸ“ Over the years, he advanced through roles including junior researcher, senior researcher, and project manager, earning his Doctor of Science along the way. šŸ”¬ His expertise spans polymer and cellulose chemistry, nanotechnology, and biomaterials. From 2019 to 2023, he served as a lab and project manager, driving innovation in nanostructured materials. šŸ’¼ Prof. Yunusov’s professional path reflects unwavering dedication to scientific discovery and technological advancement.

Research FocusĀ 

Prof. Khaydar Yunusov is a pioneering scientist whose research spans polymer chemistry, cellulose technology, and nanochemistry. His core focus lies in designing biocompatible nanomaterials 🧫 such as nanostructured drug delivery systems, microneedles, hydrogels, and functional films for medical applications šŸŽÆ. He actively explores biodegradable polymers, nanoparticle synthesis (silver, selenium, zinc oxide), and antimicrobial and anticancer therapies šŸ’Š. His work intersects biotechnology, materials science, and pharmaceutical engineering, advancing targeted treatments and regenerative medicine 🧠🦠. With numerous high-impact publications, Prof. Yunusov is shaping the future of smart biomaterials and sustainable polymeric solutions.

Publication Top Notes

  • A red cell membrane-camouflaged nanoreactor for enhanced starvation/chemodynamic/ion interference therapy for breast cancer
  • A three-dimensional printable conductive composite dressing for accelerating wound healing under electrical stimulation
  • Core-shell structured microneedles with programmed drug release functions for prolonged hyperuricemia management ( vol 12, pg 1064, 2024)
  • Fabrication of hollow microneedles with double-layer shell structure for rapid and prolonged local anesthesia
  • Homemade isothermal amplification-initiated Cas14a assay for rapid quantitative detection of aquatic RNA virus gene with no PAM
  • Iontophoresis-driven transdermal drug delivery system based on porous microneedles for hyperuricemia treatment
  • Real-time microbial growth curve (RMGC) system: an improved microplate reader with a graphical interface for automatic and high-throughput monitoring of microbial growth curves
  • Two-directions mechanical strength and high-barrier mechanisms of cellulose nanocrystal- based hybrids reinforced packaging with nacre-mimetic structure
  • Physico-chemical characteristics of dialdehyde carboxymethylcellulose/sericin graft copolymer
  • Synthesis, Characterization, and Cytotoxic Activity of Stable Selenium Nanoparticles‐Incorporated Carboxymethylcellulose Solution
  • Impact of cellulose supramolecular structure on its carboxymethylation reaction activity
  • Advances in the formation and properties of nanofiber biomaterials from polyvinyl alcohol/carboxymethylcellulose/nanosilver systems for medical applications
  • Obtaining Dialdehyde Carboxymethylcellulose Through Microwave Treatment
  • Core-shell structured microneedles with programmed drug release functions for prolonged hyperuricemia management

lingcong KONG | Drug Discovery and Development | Best Researcher Award

lingcong KONG | Drug Discovery and Development | Best Researcher Award

Prof. lingcong KONG at Jilin Agriculture University, China.

Prof. Lingcong Kong is a dedicated veterinary scientist with a Ph.D. in Preventive Veterinary Medicine from Jilin Agricultural University šŸŽ“. He teaches courses like Veterinary Pharmacology and Animal Toxicology šŸ„ and actively mentors students in national competitions šŸ†. His research focuses on antimicrobial resistance, drug resistance mechanisms, and the development of resistance inhibitors in animal pathogens 🧫🦠. He has led numerous national and provincial projects, holds multiple patents for veterinary vaccines šŸ’‰, and has published extensively in high-impact journals šŸ“š. His work significantly enhances diagnostic tools and contributes to sustainable animal healthcare.

Publication ProfileĀ 

Scopus

Education

Prof. Lingcong Kong began his academic journey at the Inner Mongolia University for Nationalities, where he earned his Bachelor of Veterinary Medicine from September 2006 to July 2010 🐾. He then pursued advanced studies at Jilin Agricultural University, completing a Master’s degree in Basic Veterinary Medicine between 2010 and 2013 🧪. Driven by a deep passion for animal health, he continued at the same institution to earn his Ph.D. in Preventive Veterinary Medicine from September 2013 to July 2016 šŸ”¬. His education laid a strong foundation for his impactful contributions to veterinary science and research.

Experience

Prof. Lingcong Kong is a dedicated educator who teaches undergraduate courses such as “Veterinary Pharmacology”, “Veterinary Pharmacology Experiment”, and “Animal Toxicology” 🐾. At the graduate level, he lectures on “Veterinary Drug Research and Creation”, “Advanced Pharmacology”, and “Veterinary Pharmacology and Toxicology” šŸ’Š. He actively mentors students in scientific competitions, leading them to prestigious honors like the 2022 Internet+ National Award (2nd Prize) šŸ…, Provincial Award (1st Prize) šŸ„‡, and innovation contests. His guidance also earned him the Outstanding Paper Award šŸ“ and the Dazenong Innovation Guidance Award in 2018 šŸŽ–ļø, highlighting his commitment to academic excellence and innovation.

Awards

Prof. Lingcong Kong has pioneered breakthroughs in detecting and combating drug-resistant animal pathogens šŸ„šŸ§«. His innovations include PCR-ELISA rapid detection, immunomagnetic bead enrichment, and high-throughput methods for resistance gene testing 🧪. He established a pathogenic bacteria resource library šŸ“š and developed functional probiotics to prevent animal diarrhea šŸ’Š. By identifying 8 key resistance inhibitor targets and 6 promising lead compounds, his work has revolutionized lab diagnostics, minimized economic losses in livestock, and enhanced ecological health šŸŒ±šŸ’¼. His efforts significantly advance animal healthcare and veterinary pharmacology across Jilin Province and beyond.

Research FocusĀ 

Prof. Lingcong Kong focuses on veterinary pharmacology, particularly targeting antimicrobial resistance and infectious diseases in animals šŸ„šŸ¦ . His cutting-edge research includes discovering novel natural inhibitors like coniferaldehyde and protocatechuic aldehyde to combat Staphylococcus aureus šŸ§ŖšŸ”¬. He also explores gene transfer mechanisms, antibiotic degradation pathways, and repurposing small molecules to inhibit bacterial enzymes like KPC-2 šŸ’Š. By studying agents such as C15-bacillomycin D and antibacterial proteins from Bacillus velezensis, he contributes significantly to combatting multidrug-resistant pathogens in animal and environmental health.

Publication Top Notes

  • Discovery of coniferaldehyde as an inhibitor of caseinolytic protease to combat Staphylococcus aureus infections
  • Anti-infective therapy of inhibiting Staphylococcus aureus ClpP by protocatechuic aldehyde
  • Acidifiers promoted antibiotic resistance gene transfer via plasmid conjugation
  • Efficient degradation of tylosin by Kurthia gibsonii TYL-A1: performance, pathway, and genomics study
  • Repurposing tavaborole to combat resistant bacterial infections through competitive inhibition of KPC-2 and metabolic disruption
  • A Novel Protein Demonstrating Antibacterial Activity Against Multidrug-Resistant Escherichia coli Purified from Bacillus velezensis CB6
  • C15-bacillomycin D produced by Bacillus amyloliquefaciens 4-9-2 suppress Fusarium graminearum infection and mycotoxin biosynthesis

Belal Hijji | Pharmacology | Best Researcher Award

Belal Hijji | Pharmacology | Best Researcher Award

Assist. Prof. Dr. Belal Hijji, Prince Sattam Bin Abdulaziz University, Saudi Arabia

Assistant Professor Dr. Belal Hijji is a distinguished nursing academic with a Ph.D. in Adult Health Nursing from the University of Ulster, UK. He has served in academic and clinical roles across Jordan, Saudi Arabia, Libya, and the UAE. With a strong focus on blood transfusion safety, he has authored books and peer-reviewed articles, including in Journal of Clinical Nursing and Nursing Reports. Dr. Hijji is passionate about nursing education, patient safety, and ethical research, and is fluent in both Arabic and English. He currently teaches at Prince Sattam bin Abdulaziz University, KSA.

Publication Profile

Google Scholar

Education

Assist. Prof. Dr. Belal Hijji is a distinguished academic with a robust background in nursing education and research. He earned his Bachelor of Nursing from Yarmouk University, Jordan (1983–1987), followed by an MSc in Nursing Studies from the University of Manchester, UK (1999–2001), where he conducted a thesis on students’ perceptions of nursing as a career. He later achieved a Ph.D. in Adult Health Nursing from the University of Ulster, UK (2003–2007), focusing on blood transfusion practices among nurses in Abu Dhabi. 🧠 In 2017, he also earned certification in human research participant protection from the NIH.

Awards

Assist. Prof. Dr. Belal Hijji has enriched his professional journey through a variety of specialized training courses. His early learning included managing hypertension and heart failure (1987) and infection control in London (1996). šŸ„ He attended the 2nd GCC Seminar on Gerontology in Abu Dhabi (1997) and gained critical appraisal skills in Oxford (2000). He also participated in conferences on healthcare ethics (2002), medical statistics (2004), and qualitative research at the University of Ulster. šŸ“Š His continuous learning extended through webinars on learning psychology (2022) and contributing to the UN Sustainable Development Goals (2022). šŸŒ Lifelong learning remains his driving force.

Experience

Assist. Prof. Dr. Belal Hijji has held numerous academic and clinical roles across the Arab world. Since September 2019, he has served as Assistant Professor of Nursing at Prince Sattam bin Abdulaziz University, KSA. šŸ‡øšŸ‡¦ Previously, he taught at Al Ghad International Colleges (2015–2019), Benghazi University, Libya (2012–2015), and the University of Ha’il (2011–2012). šŸ« Earlier roles include Assistant Professor at Philadelphia University, Jordan (2008–2010). From 1987 to 2005, he worked in diverse clinical and administrative positions within regional ministries of health. šŸ„ His leadership also included overseeing scientific affairs and curriculum development. šŸ“˜ His dedication to nursing education spans decades.

Research Focus

Assistant Professor Dr. Belal Hijji’s research primarily centers on blood transfusion knowledge and safety among nurses, with a strong emphasis on nursing education, clinical practice, and assessment tools. His studies span diverse healthcare settings in Jordan and the UAE, investigating nurses’ competencies, transfusion practices, and educational gaps. Additionally, he explores the effectiveness of assessment tools like multiple-choice questions and mathematical skills in dosage calculation, highlighting critical aspects of nursing proficiency. Through observational studies and survey research, Dr. Hijji contributes valuable insights into improving patient safety and enhancing nursing curricula.

Publication Top Notes

Knowledge of blood transfusion among nurses

Measuring knowledge of blood transfusion: A survey of Jordanian nurses

Nurses’ practice of blood transfusion in the United Arab Emirates: an observational study

Flaws of multiple choice questions in teacher-constructed nursing examinations: A pilot descriptive study

Trained nurses’ knowledge and practice of oral care on three wards in acute care hospital in Abu Dhabi, UAE

Item Analysis of the Modified Version of the Routine Blood Transfusion Knowledge Questionnaire

Knowledge and practice of blood transfusion: A survey of nurses in Abu Dhabi, United Arab Emirates

An Indispensable Requirement for Medical Dosage Calculation: Basic Mathematical Skills of Baccalaureate Nursing Students

The Science of Multiple-Choice Questions (MCQs)

Lior Zangi | Drug Discovery and Development | Best Researcher Award

Lior Zangi | Drug Discovery and Development | Best Researcher Award

Prof. Lior Zangi, Icahn School of Medicine at Mount Sinai, United States

Prof. Lior Zangi is an Associate Professor of Cardiology and Genetics & Genomic Sciences at the Icahn School of Medicine at Mount Sinai, NY. He earned his Ph.D. in Immunology from the Weizmann Institute and completed postdoctoral training at Harvard Medical School. Renowned for his pioneering work in mRNA-based cardiovascular therapies, Prof. Zangi has received prestigious awards including the AHA Postdoctoral Fellowship and an endowed professorship in Cardiovascular Research. He is a founding board member of the Society for RNA Therapeutics and actively contributes to global scientific councils, manuscript reviews, and grant panels.

Publication Profile

Google Scholar

Education

Prof. Lior Zangi šŸŽ“ began his academic journey with a B.Sc. in Biology from the Hebrew University, Givat-Ram, Jerusalem in 2000. He then earned his M.Sc. in Experimental and Developmental Medicine in 2003 from the Hebrew University Hadassah-Medical School under the guidance of Prof. Raphael Gorodetsky. In 2009, he completed his Ph.D. in Immunology at the Weizmann Institute of Science, mentored by Prof. Yair Reisner. 🌿 He continued his training as a postdoctoral fellow at Sheba Medical Center (2009–2010) under Prof. Benjamin Dekel and later at Harvard Medical School (2010–2014) with Professors Derrick Rossi and Kenneth Chien.

Awards

Prof. Lior Zangi 🌟 has earned numerous prestigious honors throughout his career. He received the ASH Travel Award in both 2008 and 2009 🧳, and in 2009, was granted a Postdoctoral Fellowship Award by the Israeli Budgeting Committee and Planning. In 2012, he was honored with both the ISSCR Travel Award and R&D Systems Travel Grant āœˆļø. His groundbreaking postdoctoral work earned him the AHA Fellowship Award in 2014 šŸ«€. In 2017, he received the Mount Sinai Faculty Idea Prize 🧠, and in 2019, his research on mRNA therapy was recognized as highly influential šŸ“œ. In 2023, he was awarded the Endowed Chan Soon-Shiong Professorship in Cardiovascular Research šŸ….

Research Focus

Prof. Lior Zangi is a pioneering researcher in cardiovascular regenerative medicine, with a special focus on modified mRNA therapies, 🧬 stem cell biology, and šŸ«€ cardiac regeneration. His work centers on developing innovative strategies for repairing damaged heart tissue using modRNA, induced pluripotent stem cells (iPSCs), and heart-on-chip technologies. Zangi’s groundbreaking research has contributed to advancements in treating conditions like myocardial infarction and Barth syndrome, and has broad implications for tissue engineering, šŸ’‰ protein replacement therapy, and immune modulation. His contributions are reshaping modern precision medicine and offering new hope for heart failure patients worldwide.

Publication Top Notes

Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

Isolation of mesenchymal stem cells from G-CSF-mobilized human peripheral blood using fibrin microbeads

Direct imaging of immune rejection and memory induction by allogeneic mesenchymal stromal cells

A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells

Isolation and characterization of nontubular sca-1+ lināˆ’ multipotent stem/progenitor cells from adult mouse kidney

Pkm2 regulates cardiomyocyte cell cycle and promotes cardiac regeneration

mRNA-based protein replacement therapy for the heart

Altering sphingolipid metabolism attenuates cell death and inflammatory response after myocardial infarction

Nitika Mor | Drug Discovery and Development | Best Researcher Award

Nitika Mor | Drug Discovery and Development | Best Researcher Award

Dr. Nitika Mor, Baba Mastnath University, Asthal Bohar, Rohtak (HR), India

Dr. Nitika Mor is an accomplished Assistant Professor of Chemistry at Baba Mastnath University, Rohtak, with a Ph.D. in Pharmaceutical Chemistry from Kurukshetra University. Her research focuses on drug delivery systems, traditional medicinal formulations, and molecular docking. She has published 14 research papers, authored a book chapter, holds two patent publications (one granted), and has received multiple awards including the UGC-CSIR JRF/SRF and Best Poster Award. With technical expertise in synthesis, biological assays, and in-silico studies, Dr. Mor is a dynamic contributor to pharmaceutical research and innovation.

Publication Profile

Google Scholar

Education

Dr. Nitika Mor is a dedicated researcher with a Ph.D. in Chemistry from Kurukshetra University (2017–2022), where she focused her thesis on the Design, Characterization, and In-Vitro Studies of Sustained Release Delivery Systems for Curcumin under the guidance of Dr. Neera Raghav. šŸŽ“ She holds an M.Sc. in Organic Chemistry (2013–2015) from Hindu College, Sonipat, affiliated with Maharishi Dayanand University, Rohtak. 🧪 Her academic journey began with a B.Sc. in Physics, Chemistry, and Mathematics (2010–2013) from Hindu Girls College, Sonipat. šŸ“š Dr. Mor’s educational background reflects a strong foundation in science and innovative pharmaceutical research.

Experience

Dr. Nitika Mor is currently serving as an Assistant Professor in the Department of Chemistry at Baba Mastnath University, Rohtak, since February 1, 2023. šŸ›ļø With her strong academic foundation and research expertise in pharmaceutical and organic chemistry, she brings innovative teaching methods and deep subject knowledge to the classroom. 🧪 Her role involves mentoring students, delivering engaging lectures, and contributing to the academic growth of the department. šŸ“š Dr. Mor’s commitment to education and passion for chemistry make her a valuable asset to the university’s faculty. ✨ She continues to inspire budding scientists through her teaching and guidance.

Awards

Dr. Nitika Mor has received several prestigious awards and fellowships in recognition of her academic excellence and research potential. She qualified the UGC-CSIR JRF (Chemical Sciences) in June 2016 with an impressive All India Rank of 65. šŸ‡®šŸ‡³ She was awarded the Junior Research Fellowship (JRF) from October 2017 to September 2019, followed by the Senior Research Fellowship (SRF) from October 2019 to March 2022 by UGC-CSIR India to support her Ph.D. journey. šŸ”¬ In 2018, she received the Best Poster Presentation Award at the 9th National Conference on RACES-2018 held at MMM College, Patiala, Punjab.

Research Focus

Dr. Nitika Mor specializes in pharmaceutical and biomedical sciences, with a strong research focus on natural polymer-based oral drug delivery systems. Her work emphasizes the use of biopolymers like cellulose, pectin, carrageenan, and alginate for sustained release formulations, particularly for curcumin. She explores modifications of polysaccharides and curcumin derivatives to improve bioavailability, pharmacokinetics, and therapeutic efficacy. Her contributions also span phytochemistry, investigating medicinal plants like Ashwagandha and Garlic for their pharmacological benefits. Dr. Mor integrates green chemistry, molecular modeling, and clinical insights into her innovative drug delivery strategies.

Publication Top Notes

Recent advances in cellulose, pectin, carrageenan and alginate-based oral drug delivery systems

Some cetyltrimethylammonium bromide modified polysaccharide supports as sustained release systems for curcumin

Design and development of carboxymethylcellulose ester of curcumin as sustained release delivery system in liver

Synthesis of propynyloxy substituted some novel aurones as potent cathepsin B inhibitors

Alginate hydrogels: Sustained release system to analyze the effect of traditional excipients on curcumin availability

Study on enhanced serum protein protecting and anti-cathepsin activities of various curcumin formulations containing traditional excipients and bio-enhancers

In-vitro simulation of modified-alginate ester as sustained release delivery system for curcumin

Curcumin, the panacea: A review on advancement to solve pharmaco-kinetic problems.

A review: Phytochemicals and bioactivities of Ashwagandha (Withania somnifera).

KYU SHIK MUN | Personalized Medicine | Best Researcher Award

KYU SHIK MUN | Personalized Medicine | Best Researcher Award

Assist. Prof. Dr. KYU SHIK MUN, Cedars-Sinai Medical Center, United States

Assist. Prof. Dr. Kyu Shik Mun is a distinguished researcher in cystic fibrosis (CF) and biomedical engineering 🧬. As a Principal Investigator and Co-Director, he has led groundbreaking projects on CF-related diabetes, organ-on-a-chip models, and personalized CF therapy šŸ„. His work, funded by organizations like the Cystic Fibrosis Foundation and Vertex Pharmaceuticals, has yielded significant patents and high-impact publications šŸ“‘. With 733 citations, an h-index of 10, and an i10-index of 10, Dr. Mun continues to drive innovations in CF research, bridging biomedical science and translational medicine šŸ”¬.

Publication Profile

Google Scholar

Professional Background

Assist. Prof. Dr. Kyu Shik Mun earned his Ph.D. in the Materials Science and Engineering Program at the University of Cincinnati šŸŽ“. In 2016, he joined the Cystic Fibrosis Research Center at Cincinnati Children’s Hospital, where he pioneered a microfluidic-based organ-on-chip program from scratch šŸ„šŸ§¬. His groundbreaking research focused on studying cystic fibrosis and related disorders. In 2021, he was promoted to Assistant Professor at Cedars-Sinai šŸ†, where he continues to advance in vitro cell culture models using organ-on-chip technology and 3D bioprinting šŸ–ØļøšŸ”¬, contributing to innovative solutions in biomedical research and personalized medicine.

Awards

Assist. Prof. Dr. Kyu Shik Mun has received numerous prestigious honors and awards throughout his academic and professional journey šŸŽ–ļø. He was awarded multiple Outstanding Grade Scholarships at Gangneung National University šŸ… (2000–2009) and recognized for excellence with department and presidential awards šŸ†. His achievements include a scholarship from the Korean Broadcasting System šŸ“ŗ and the Korea Research Foundation šŸŒ. During his Ph.D. at the University of Cincinnati, he earned a University Graduate Scholarship šŸŽ“ (2010–2014). His research has been recognized by the American Gastroenterological Association and the Cystic Fibrosis Foundation 🧬, receiving multiple Best Abstract and Early Career Investigator awards (2017–2024) šŸ„‡.

ExperienceĀ 

Assist. Prof. Dr. Kyu Shik Mun has been actively involved in non-clinical teaching, contributing to journal clubs and lab mentoring šŸ“ššŸŽ¤. He has delivered key presentations on organ-on-a-chip technology 🧬, including talks at Cincinnati Children’s Hospital (2020) and Cedars-Sinai (2021) šŸ„. His mentorship spans postdoctoral fellows, research associates, and Ph.D. students, guiding projects in 3D bioprinting šŸ–Øļø and patient-derived lung-on-a-chip models šŸŒ¬ļø. Since 2016, he has mentored 15 summer and rotation students—including high school, college, Ph.D., and MD candidates—on fabricating organ-on-a-chips and culturing cells, fostering the next generation of biomedical researchers šŸ”¬.

Research Focus

Assist. Prof. Dr. Kyu Shik Mun’s research primarily focuses on nanotechnology 🧪, biosensors 🧫, and biomedical engineering šŸ„. His work spans optical interferometric biosensors for label-free detection, organ-on-a-chip models for diseases like cystic fibrosis 🫁, and TiOā‚‚ nanotube arrays for applications in solar cells ā˜€ļø and photocatalysis. He also explores drug discovery šŸ’Š by targeting molecular pathways in cystic fibrosis and related disorders. His interdisciplinary research integrates materials science šŸ—ļø, biophysics āš›ļø, and microfluidics šŸ”¬ to develop innovative medical technologies, aiming to advance precision medicine šŸŽÆ and renewable energy solutions 🌱.

Publication Top Notes

A Stable, Label-free Optical Interferometric Biosensor Based on TiO2Ā Nanotube Arrays

Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders

Guided construction of single cell reference for human and mouse lung

Targeting the pregnane X receptor using microbial metabolite mimicry

Personalized medicine in CF: from modulator development to therapy for cystic fibrosis patients with rare CFTR mutations

Surface passivation of highly ordered TiO2 nanotube arrays and application to dye-sensitized solar cells using the concept of isoelectric point

Targeting DNAJB9, a novel ER luminal co-chaperone, to rescue ΔF508-CFTR

Guanylate cyclase 2C agonism corrects CFTR mutants

Cystic Fibrosis Human Organs-on-a-Chip

Ms. Faezeh Aghajannataj Ahangarkola|Drug Delivery Systems | Best Researcher Award

Ms. Faezeh Aghajannataj Ahangarkola |Drug Delivery Systems|Best Researcher Award|

Ms. Faezeh Aghajannataj Ahangarkola at Babol Noshirvani University of Technology,Iran

PROFILEĀ Ā 

Google scholar

 

Early Academic Pursuits šŸŽ“

Faezeh Aghajannataj began her academic journey with a strong foundation in pure chemistry, earning a Bachelor of Science degree from the University of Mazandaran (UMZ) in Babolsar, Iran, in September 2018. Her undergraduate studies focused on the synthesis of pharmaceutical heterocyclics, particularly through multi-component reactions. Under the guidance of Dr. Robabeh Baharfar, Faezeh’s final project received a stellar grade of 4.0/4.0, demonstrating her early aptitude for research and her keen interest in the intersection of chemistry and pharmaceuticals.

Building on her success at UMZ, Faezeh pursued a Master of Science degree in Biotechnology at the Babol Noshirvani University of Technology (BNUT), Babol, Iran. Her graduate research centered on the development of enteric hard capsules for targeting the small intestine, utilizing innovative materials like Pullulan and Eudragit L-100. This research culminated in a thesis titled “Enteric Hard Capsules for Targeting Small Intestine by Pullulan and Eudragit L-100: Processing, Characterization, and In-vitro Drug Release,” which was awarded a perfect grade of 4.0/4.0 (19/20), reflecting the high quality and significance of her work under the mentorship of Dr. Ghasem Najafpour.

Professional Endeavors šŸ¢

Faezeh’s professional career is marked by a strong focus on research and development in the pharmaceutical and biotechnology industries. During her time at Iran Gelatin Capsule in Tehran, she played a pivotal role as a member of the R&D team from February 2022 to May 2023. Her work primarily involved researching and formulating pullulan capsules at an industrial scale, a task that required both technical expertise and innovative thinking. Additionally, she contributed to the formulation and evaluation of controlled release systems designed to produce enteric-coated capsules without synthetic materials or external coatings, a project that aligns with the growing demand for more natural and sustainable pharmaceutical solutions.

Faezeh also gained significant experience as a teaching assistant during her academic career. She assisted in courses such as Organic Chemistry Laboratory and Physical Chemistry Laboratory at UMZ, and Advanced Engineering Mathematics at BNUT, showcasing her ability to convey complex scientific concepts to students. Her teaching roles not only enriched her understanding of the subjects but also allowed her to contribute to the academic growth of her peers.

Contributions and Research Focus šŸ”¬

Faezeh’s research interests lie at the crossroads of biotechnology, pharmaceutical sciences, and chemistry. Her master’s thesis on enteric hard capsules represents a significant contribution to the field of drug delivery systems, particularly in the development of targeted delivery mechanisms for the small intestine. This work, which involved detailed processing, characterization, and in-vitro drug release studies, has the potential to impact the way oral medications are formulated and administered, particularly in terms of improving drug efficacy and patient outcomes.

Her research has been recognized through the publication of her work in reputable scientific journals. One notable publication is “Towards a Novel Pullulan and Pullulan-Enteric Hard Capsules: Study of Drug Release and Crucial Capsule Features,” co-authored with Dr. Gh. Najafpour and R. Ramezani. This paper, accessible , highlights the innovative approach Faezeh has taken in her research, contributing valuable knowledge to the field of drug delivery systems.

Accolades and Recognition šŸ†

Throughout her academic and professional career, Faezeh has consistently achieved high marks and recognition for her work. Her thesis was awarded a perfect grade, reflecting the high esteem in which her research is held. Additionally, her academic achievements during her bachelor’s and master’s studies are underscored by her strong GPA, which stands at 3.6/4.0 (16.95/20) for her master’s degree, and her consistently high grades in her coursework.

Her work has also been recognized within the academic community through her roles as a teaching assistant, where she earned the trust of her professors to guide and mentor students in complex scientific subjects.

Impact and Influence šŸŒ

Faezeh’s research on drug delivery systems, particularly her focus on enteric capsules, has the potential to significantly impact the pharmaceutical industry. By developing more effective and targeted drug delivery mechanisms, her work could lead to improved patient outcomes, particularly for those with conditions that require precise delivery of medication to the small intestine.

Her influence extends beyond her research, as her roles as a teaching assistant and R&D member have allowed her to mentor and collaborate with others in the field, spreading her knowledge and fostering innovation in both academic and industrial settings.

Legacy and Future Contributions 🌟

Faezeh Aghajannataj is poised to make lasting contributions to the fields of biotechnology and pharmaceutical sciences. Her innovative approach to drug delivery systems and her commitment to research excellence set her apart as a leading figure in her field. As she continues her career, her work is likely to inspire future research and development in the industry, particularly in the creation of more sustainable and effective pharmaceutical solutions.

šŸŽ“PublicationĀ 

Ethanol fermentation in an immobilized cell reactor using Saccharomyces cerevisiae

  • AuthorsĀ  Ā :Ghasem Najafpour, Habibollah Younesi, Ku Syahidah Ku Ismail
  • JournalĀ  Ā  :Bioresource technology
  • YearĀ  Ā  Ā  Ā  Ā :2024

Piperine—the bioactive compound of black pepper: from isolation to medicinal formulations

  • AuthorsĀ  Ā :Leila Gorgani, Maedeh Mohammadi, Ghasem D Najafpour, Maryam Nikzad
  • JournalĀ  Ā  :Comprehensive reviews in food science and food safety
  • YearĀ  Ā  Ā  Ā  Ā :2017

High-rate anaerobic digestion of palm oil mill effluent in an upflow anaerobic sludge-fixed film bioreactor

  • AuthorsĀ  Ā :GD Najafpour, AAL Zinatizadeh, AR Mohamed, M Hasnain Isa, H Nasrollahzadeh
  • JournalĀ  Ā  :Process Biochemistry
  • YearĀ  Ā  Ā  Ā  Ā :2006

Treatment of pulp and paper mill wastewater by polyacrylamide (PAM) in polymer induced flocculation

  • AuthorsĀ  Ā :SS Wong, TT Teng, AL Ahmad, A Zuhairi, G Najafpour
  • JournalĀ  Ā  :Journal of hazardous materials
  • YearĀ  Ā  Ā  Ā  Ā :2006

Power generation from organic substrate in batch and continuous flow microbial fuel cell operations

  • AuthorsĀ  Ā :Mostafa Rahimnejad, Ali Asghar Ghoreyshi, Ghasem Najafpour, Tahereh Jafary
  • JournalĀ  Ā  :Applied Energy
  • YearĀ  Ā  Ā  Ā  Ā :2011